Home > Insider Trading > Filing (0001104659-19-020868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1556263	Syros Pharmaceuticals Inc.	SYRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253170	Srinivas Akkaraju	C/O Syros Pharmaceuticals, Inc. 620 Memorial Drive, Suite 300 Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-09	533,332	$7.50	1,593,270	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (rights to buy)	Acquisiton	2019-04-09	133,333	$0.00	133,333	$8.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
133,333	2019-04-09	2022-10-10	No	4	P	Indirect

Footnotes

The reported securities were purchased for $7.50 per share of common stock and accompanying warrants. The shares of common stock and warrants were purchased in combination, with 0.25 warrants to purchase a share of common stock accompanying each share of common stock.
Securities held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of the Reporting Person's pecuniary interest therein.